Hepatitis B future or investigational therapies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Overview
Currently, new forms of treatment (such as the combination therapy of interferon-α with lamivudine for patients who failed interferon-α monotherapy) are under investigation.[1] Future studies and monitoring are required to evaluate the genotypic resistance of HBV to nucleoside and nucleotide therapy.[2]
References
References
- ↑ “Hepatitis B”.
- ↑ Lin CL, Kao JH (2011). “The clinical implications of hepatitis B virus genotype: Recent advances”. J Gastroenterol Hepatol. 26 Suppl 1: 123–30. doi:10.1111/j.1440-1746.2010.06541.x. PMID 21199523.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH